We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bristol-Myers Squibb and Promedior Enters into Agreement

News   Sep 03, 2015

 
Bristol-Myers Squibb and Promedior Enters into Agreement
 
 
 

RELATED ARTICLES

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

Topical Immunotherapy Lowers Risk of Skin Cancer

News

A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE